| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Immunitybio, Inc. (IBRX) have been net sellers, shedding 106,056 shares worth roughly $1.1M on balance. In the past 30 days, 0 insiders bought and 2 sold. Sales set the recent tone.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), IBRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 251.02M | $1.36B | - | |
| Dir | 2.78M | $29.86M | -25,000 | |
| CEO | 560.3K | - | - | |
| CFO | 300.1K | - | - | |
| Other | 115.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Simon Barry J.79 | Director | Sell10b5-1 | 151,967 | $7.20 | $1,094,296.68 | -4.7% | +26.5% | - | |
| Jan 20, 2026 | Selecky Christobel | Director | Sale+OE10b5-1 | 75,000 | $5.84 | $437,650.00 | - | +26.5% | - | |
| Jun 5, 2023 | Blaszyk Michael D | Director | Buy | 71,915 | $2.75 | $198,023.35 | New | -47.7% | +120.4% | |
| Jun 2, 2023 | Brennan John Owen | Director | Buy | 25,000 | $2.83 | $70,700.00 | New | -41.9% | +131.8% | |
| Jun 1, 2023 | Clark Wesley | Director | Buy | 7,000 | $2.91 | $20,370.00 | +700.0% | -43.9% | +118.4% | |
| Oct 8, 2021 | Adcock Richard | CEO &President | Buy | 1,930 | $8.81 | $16,995.02 | New | -29.2% | -41.9% | |
| Aug 23, 2021 | Cohen Cheryl77 | Director | Sell | 24,777 | $10.07 | $249,602.89 | -11.0% | -43.9% | -64.1% | |
| Aug 18, 2021 | Cohen Cheryl77 | Director | Sell | 45,531 | $10.12 | $460,750.44 | -16.8% | -24.4% | -53.6% | |
| May 25, 2021 | Simon Barry J.79 | Director | Sell | 125,000 | $16.14 | $2,018,056.87 | -3.9% | -31.0% | -77.8% | |
| Feb 5, 2021 | Simon Barry J.79 | See Remarks | Sale+OE | 22,100 | $23.09 | $510,266.90 | -0.7% | - | - |